Cholecalciferol and calcifediol for vitamin D supplementation

  • M. Sosa-HenríquezEmail author
Letter to the Editor



  1. 1.
    Quesada-Gómez JM, Bouillon R (2018) Is calcifediol better than cholecalciferol for vitamin D supplementation? Osteoporos Int 29(8):1697–1711CrossRefGoogle Scholar
  2. 2.
    EFSA (European Food Safety Authority) (2005) Opinion of the scientific panel on additives and products or substances used in animal feed on a request from the Commission on the evaluation of safety and efficacy of “Hy•D” (calcifediol), based on 25-hydroxylcholecalciferol/25-hydroxy-pre-cholecalciferol, as feed additive in accordance with Council Directive 70/524/EEC. (Question No. EFSA-Q-2004-065). Adopted on 26 May 2005. EFSA J 224:1–35Google Scholar
  3. 3.
    Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP et al (2011) Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930CrossRefGoogle Scholar
  4. 4.
    Olmos JM, Arnaiz F, Henández JL, Olmos-Martínez JM, González-Macías J (2018) Monthly versus biweekley calcifediol in the treatment of osteoporotic patients. Study in real life. Rev Osteoporos Metab Miner 10(2):89–95Google Scholar
  5. 5.
    IoM (Institute of Medicine) (2010) Dietary reference intakes for calcium and vitamin D. National Academies Press, Washington, D.C. 1133 ppGoogle Scholar
  6. 6.
    Peacock M, Liu G, Carey M, McClintock R, Ambrosius W, Hui S, Johnston CC (2000) Effect of calcium or 25OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60. J Clin Endocrinol Metab 85(9):3011–3019PubMedGoogle Scholar
  7. 7.
    Reyes Domínguez AI, Gómez de Tejada Romero MJ, Sosa-Henríquez M (2017) Vitamin D. Physiology. Its use in the treatment of osteoporosis. Rev Osteoporos Metab Miner 9(Supl 1):S5–S9 3Google Scholar
  8. 8.
    Sosa-Henríquez M, Gómez de Tejada Romero MJ (2014) Treatment of osteoporosis. Medicine 11(60):3545–3554Google Scholar
  9. 9.
    Dawson-Hughes B, Mithal A, Bonjour JP, Boonen S, Burckhardt P, Fuleihan GE, Josse RG, Lips P, Morales-Torres J, Yoshimura N (2010) IOF position statement: vitamin D recommendations for older adults. Osteoporos Int 21(7):1151–1154CrossRefGoogle Scholar
  10. 10.
    Kanis JA, Cooper C, Rizzoli R, Reginster JY, Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF) (2019) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 30(1):3–44CrossRefGoogle Scholar
  11. 11.
    Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R, National Osteoporosis Foundation (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10):2359–2381CrossRefGoogle Scholar
  12. 12.
    Aspray TJ, Bowring C, Fraser W, Gittoes N, Javaid MK, Macdonald H, Patel S, Selby P, Tanna N, Francis RM, National Osteoporosis Society (2014) National Osteoporosis Society vitamin D guideline summary. Age Ageing 43(5):592–595CrossRefGoogle Scholar
  13. 13.
    Camacho PM, Petak SM, Binkley N, Clarke BL, Harris ST, Hurley DL et al (2016) American Association of Clinical Endocrinologists and American college of Endocrinology practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis - 2016. Endocr Pract 22(Suppl 4):1–42CrossRefGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2019

Authors and Affiliations

  1. 1.University of Las Palmas de Gran Canaria, University Institute of Investigation on Biomedical Sciences (IUIBMS)Las Palmas de Gran CanariaSpain
  2. 2.Bone Metabolic UnitHospital University InsularLas Palmas de Gran CanariaSpain

Personalised recommendations